PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
On this page
  1. Programs that ship to Washington, DC
  2. Does DC Medicaid cover it?
  3. What changed, and when
  4. DC Medicaid in numbers
  5. Medicare in every state
  6. Neighbouring states
  7. Common questions
  8. Sources

Which GLP-1 programs ship to Washington, DC?

None on a state list we could verify. Every program we track either serves most states without naming which, or names Washington, DC as not served.

Cheapest first by what leaves your account each month, membership fees included, then the shorter plan. Each is a telehealth program: a clinician licensed in Washington, DC reviews you online and a pharmacy mails the medication. Prices checked November 2026.

State list not verified · No program we track lists Washington, DC separately, so we cannot say which ship there: Wellmedr (50 states), Embody (49 states), SnagRx (49 states), Gala Health (50 states), Collective (44 states), CoreAge Rx (48 states), Idun Rx (state list not published), Belle (state list not published), Eden (50 states), Arbor (state list not published), bmiMD (50 states), Sprout Health (44 states), Oak Longevity (50 states), HealthRX (50 states), Mochi Health (state list not published), PeterMD (46 states), Bodybuilding.com Health+ (50 states), Strut Health (49 states), Found (50 states), EverPrime (Enhance MD) (39 states), ShedRx (50 states), DudeMeds (46 states), SkinnyRx (48 states), RxSpan MD (49 states), Sesame Care (50 states), Lemonaid Health (state list not published), Direct Meds GLP-1 (49 states), Wellorithm (50 states), GoodLife Health (50 states).

Does DC Medicaid cover GLP-1s for weight loss?

Not covered for weight loss

DC Medicaid's Wegovy and Zepbound forms say anti-obesity drugs are excluded from coverage, so it does not cover them for weight loss in its fee-for-service pharmacy program. Read from state documents Nov 6, 2026.

What DC Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. DC Department of Health Care Finance.

This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.

What changed, and when

  • Nov 6, 2026 · This pageFirst read from DC Department of Health Care Finance documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.

Weight loss

Not covered, read Nov 2026

Type 2 diabetes

Required in every state

Heart risk, sleep apnea

Required (Wegovy, Zepbound)

Prior authorization

Typical when covered

Wegovy, Zepbound, Saxenda, 2025

538 prescriptions

Ozempic and Mounjaro, 2025

21,667 prescriptions

Neighbours covering weight loss

1 of 2

Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your DC Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.

For comparison, a dated secondary source: KFF's January 2026 map listed DC Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.

The BALANCE model

CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether DC Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.

The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.

How many GLP-1s does DC Medicaid pay for?

27,754 GLP-1 prescriptions in 2025, 44th of the 50 states and DC, with $22.0 million reimbursed before rebates. Counting the share other payers covered, $28.1 million.

Prescriptions, 2025

27,754

44th of 51

Medicaid paid

$22.0M

43rd of 51, before rebates

Per prescription

$794

$1,051 nationally

Weight-loss brands

1.9%

34th highest share of 51

Medicaid GLP-1 prescriptions, 2025
  1. Virginia227K
  2. Maryland148K
  3. Washington, DC27.8K

CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Washington, DC is highlighted. CMS publishes this comparison as one year, not a trend.

Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 1.9% of DC Medicaid's GLP-1 prescriptions in 2025 (538). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was DC Medicaid's most filled GLP-1.

DC Medicaid GLP-1 prescriptions by brand, 2025. Before rebates.
BrandPrescriptionsShareMedicaid paidPer Rx
Ozempic15,98658%$13.0 million$814
Mounjaro5,68120%$4.8 million$837
Trulicity5,23219%$3.8 million$725
Zepboundapproved for weight management3581.3%$240,849$673
Rybelsus3031.1%$116,802$385
Wegovyapproved for weight management1800.6%$130,694$726
Bydureon140.1%$119$8

Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.

On Medicare in Washington, DC?

Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.

medicare.gov

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026

Washington, DC and the states around it

Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.

1 of the 2 states next to Washington, DC covers GLP-1s for weight loss through Medicaid: Virginia.

Washington, DC and the states around it. Medicaid from state documents where read, otherwise KFF, January 2026. Cash prices checked November 2026.
StateMedicaid, weight lossShip thereCheapest that ships there
Washington, DCNot covered0none verified
MarylandNot covered19$39/moWellmedr
VirginiaCovered19$39/moWellmedr

GLP-1s in Washington, DC: common questions

Does DC Medicaid cover Wegovy or Zepbound for weight loss?

DC Medicaid's Wegovy and Zepbound forms say anti-obesity drugs are excluded from coverage, so it does not cover them for weight loss in its fee-for-service pharmacy program. Read from state documents Nov 6, 2026. Wegovy: no. Zepbound: no. Ozempic: no. Mounjaro: no. Coverage can differ in a managed care plan, so ask your plan before you fill.

Does DC Medicaid cover Ozempic or Mounjaro for diabetes?

Yes. Weight-loss coverage is optional for states, but Medicaid must cover GLP-1s approved for type 2 diabetes, so Ozempic, Mounjaro and the others are covered for blood sugar in Washington, DC as in every state, usually behind prior authorization. Wegovy for heart risk and Zepbound for sleep apnea are required uses too (KFF). In 2025 DC Medicaid paid for 15,986 Ozempic and 5,681 Mounjaro prescriptions (CMS).

Has DC Medicaid joined the BALANCE model?

We could not find a published list of the state Medicaid programs taking part, so we cannot say. BALANCE is a voluntary CMS model: states could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026 (KFF). It does not change what you pay, because federal law already limits Medicaid out-of-pocket costs to nominal amounts. Ask DC Medicaid whether it joined.

How many GLP-1 telehealth programs ship to Washington, DC?

0 of the 29 partner programs we track ship to Washington, DC on a state list we could verify. None of them names Washington, DC as a state it does not serve. 29 publish a state count without the list, so we cannot say: Wellmedr, Embody, SnagRx, Gala Health, Collective, CoreAge Rx, Idun Rx, Belle, Eden, Arbor, bmiMD, Sprout Health, Oak Longevity, HealthRX, Mochi Health, PeterMD, Bodybuilding.com Health+, Strut Health, Found, EverPrime (Enhance MD), ShedRx, DudeMeds, SkinnyRx, RxSpan MD, Sesame Care, Lemonaid Health, Direct Meds GLP-1, Wellorithm, GoodLife Health.

How many GLP-1 prescriptions did DC Medicaid pay for in 2025?

27,754, 44th of the 50 states and DC, with $22.0 million reimbursed before rebates (CMS State Drug Utilization Data). Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 1.9% of those prescriptions.

Can I get a GLP-1 for $50 a month on Medicare in Washington, DC?

If you have Medicare Part D and meet the rules, yes. Medicare's temporary GLP-1 Bridge is the same in every state: medicare.gov says "This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)" and "You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)." (read Nov 14, 2026).

Do the states next to Washington, DC cover GLP-1s for weight loss?

1 of the 2 states next to Washington, DC covers GLP-1s for weight loss through Medicaid: Virginia.

Sources

Program prices are read off each seller’s own page weekly; the last check behind this page was November 2026. The Medicaid answer comes from the state's own documents, quoted below with the day we read each one, and is re-read monthly. KFF is a dated secondary source. The prescription figures are CMS’s.

1

Wegovy · DC Department of Health Care Finance (Prime Therapeutics, DC PBM)

“Please note: anti-obesity drugs are excluded from coverage for the District DHCF Pharmacy Program.”

https://www.dc-pbm.com/documents/d/dc-pbm/dc_wegovy_pa_request_form · read Nov 6, 2026

2

Zepbound · DC Department of Health Care Finance (Prime Therapeutics, DC PBM)

“Note: Anti-obesity drugs are excluded from coverage for the District DHCF Pharmacy Program.”

https://www.dc-pbm.com/documents/d/dc-pbm/district_zepbound_pa_request_form · read Nov 6, 2026

3

Ozempic · DC Department of Health Care Finance (Prime Therapeutics, DC PBM)

“Does the member have a diagnosis of Type 2 Diabetes (not pre-diabetes)?”

https://www.dc-pbm.com/documents/d/dc-pbm/district_glp-1_pa_request_form · read Nov 6, 2026

4

Ozempic · DC Department of Health Care Finance (Prime Therapeutics, DC PBM)

“Please note GLP-1 drugs FDA labeled for weight loss are excluded from coverage for the District DHCF Pharmacy Program.”

https://www.dc-pbm.com/documents/d/dc-pbm/district_glp-1_pa_request_form · read Nov 6, 2026

5

Mounjaro · DC Department of Health Care Finance (Prime Therapeutics, DC PBM)

“Does the member have a diagnosis of Type 2 Diabetes (not pre-diabetes)?”

https://www.dc-pbm.com/documents/d/dc-pbm/district_glp-1_pa_request_form · read Nov 6, 2026

6

Mounjaro · DC Department of Health Care Finance (Prime Therapeutics, DC PBM)

“Please note GLP-1 drugs FDA labeled for weight loss are excluded from coverage for the District DHCF Pharmacy Program.”

https://www.dc-pbm.com/documents/d/dc-pbm/district_glp-1_pa_request_form · read Nov 6, 2026

7

KFF state map, the District of Columbia row, as of January 2026 (secondary, dated)

“District of Columbia,DC,Not covered”

https://datawrapper.dwcdn.net/GL0OB/8/dataset.csv · read Nov 14, 2026

8

KFF, published Jan 16, 2026

“13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Nov 14, 2026

9

KFF, what Medicaid must cover

“coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Nov 14, 2026

10

KFF, required uses besides diabetes

“for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound)”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Nov 14, 2026

11

KFF, prior authorization

“When covered, GLP-1s are typically subject to utilization controls such as prior authorization, which can further limit access.”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Nov 14, 2026

12

KFF on BALANCE, state rollout

“For state Medicaid agencies that opt to participate in the model, implementation will be on a rolling basis from May 1, 2026 through January 1, 2027.”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Nov 14, 2026

13

KFF on BALANCE, deadlines

“The date for manufacturers to notify CMS of their interest in participating was January 8, 2026; for Medicare Part D plans was April 20, 2026; and for state Medicaid programs is July 31, 2026”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Nov 14, 2026

14

KFF on BALANCE, what you pay

“The model will not affect out-of-pocket costs for Medicaid enrollees, which are limited to nominal amounts under federal law.”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Nov 14, 2026

15

Medicare, the GLP-1 Bridge

“This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)”

https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026

16

Medicare, the Bridge copay

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026

17

CMS dataset

State Drug Utilization Data 2025, CMS State Drug Utilization Data, data.medicaid.gov

https://data.medicaid.gov/dataset/158a1baa-5506-400a-8ec3-97756f0b0536 · updated by CMS Jul 13, 2026

Full brief: KFF, Medicaid Coverage of and Spending on GLP-1s. Not insurance or medical advice: your plan and your prescriber decide.

Programs add states. We check weekly.

One email when a program that ships to Washington, DC gets cheaper.

Every state